RELATIONSHIP BETWEEN LIPID PROFILE RESULTS AND THE LEVEL OF MATRIX METALLOPROTEINASES IN BLOOD SERUM IN APPARENTLY HEALTHY WOMEN OF DIFFERENT AGES



Cite item

Full Text

Abstract

AbstractSolving the problem of active longevity is extremely important both for humanity as a whole and for each individual. There is no unified theory of aging today. Gerontologists agree that aging is caused by many causes acting simultaneously or sequentially. At the same time, most modern theories are based on the study of individual processes occurring during the aging of the body. Aging alters lipid metabolism by regulating several important pathways involved in lipid transport. In addition, the retention of cholesterol-rich lipoprotein apeS in the artery wall causes several modifications and important biological consequences, including due to the influence of matrix metalloproteinases (MMPs), the expression of which increases with age. The aim of the study was to analyze the values of lipidogram, matrix metalloproteinases in women with age and to assess their relationship.  The study included 157 women, distributed by age (WHO). The subjects underwent the first stage of medical examination at the clinical bases of the Federal State Budgetary Educational Institution of the Russian Ministry of Health, where the levels of total cholesterol, high-density lipoproteins, low-density lipoproteins, triglycerides, apoliproteins A1, B and MMP values in blood serum were determined. Statistical processing of the obtained results was carried out using the IBM SPSS Statistics 26 program using nonparametric statistics methods. In conditionally healthy women, depending on age, the level of OH was high at the age of 45-59 years, in senile age it was significantly reduced. HDL was significantly reduced in the senile age group, while LDL was, on the contrary, increased. The level of APA in women under 45 years of age was reduced, and at the age of 60-74 years it was increased. The ApoV/ApoA1 index was lower at a young age compared to women over 45 years of age. In conditionally healthy women, MMP-1 values were higher in the middle-aged group. MMP-2 was higher in the middle-aged group, but its highest levels were recorded in the group of women over 75 years old. MMP-3 did not change depending on age. In women over 75 years of age, MMP-7 was lower than the values of the other groups. MMP-9 was higher in the group of women aged 45-59 years. According to the conducted correlation analysis, conditionally healthy women had direct medium-strength connections between the level of APA and MMP-2, which correlated with an increase in age.

About the authors

Sergeevna Chepurnova

Pacific State Medical University, Vladivostok, Russian Federation

Email: Dr.cns@yandex.ru
ORCID iD: 0000-0001-6642-1332
SPIN-code: 6726-8523

candidate of Medical Sciences, Associate proffesor of the Department of normal and pathological physiology

Russian Federation, 2 Ostryakova Ave.Vladivostok 690002, Russia

Vladimir Nikolaevich Jushhuk

Pacific State Medical University, Vladivostok, Russian Federation

Email: Dr.cns@yandex.ru
SPIN-code: 7096-1850

assistant  of the Department of public health

Russian Federation, 2 Ostryakova Ave.Vladivostok 690002

Elena Vladimirovna Markelova

Pacific State Medical University, Vladivostok, Russian Federation

Email: markev2010@mail.ru
ORCID iD: 0000-0001-5846-851X
SPIN-code: 3661-5026

Professor, Doctor of Medical Sciences, Head  of the Department of normal and pathological physiology

Russian Federation, 2 Ave Ostryakova Ave. Vladivostok 690002

Margarita Alekseevna Visjagina

Pacific State Medical University, Vladivostok, Russian Federation

Author for correspondence.
Email: margovisyagina@gmail.com

Associate Professor,  Department normal and pathological physiology

Russian Federation, 2 Ostryakova Ave., Vladivostok, 690002

References

  1. Грачев Н.И., Красников В.Е., Турмова Е.П., Маркелова Е.В., Рублев В.Ю., Назаренко С.А. Анализ показателей матриксной металлопротеиназы-9, тканевого ингибитора матриксных металлопротеиназ 1-го типа и их комплекса у пациентов с острым инфарктом миокарда, подвергшихся чрескожным коронарным вмешательствам // Тихоокеанский медицинский журнал - 2018. - № 4 (74). - С. 45-48. Grachev N.I., Krasnikov V.E., Turmova E.P., Markelova E.V., Rublev V.Yu, Nazarenko S.A. Аnalysis of matrix metalloproteinase-9, tape inhibitor of matrix metalloproteinase type 1 and their complex in patients with acute miocard infarction who have exposed high coronary interventions // Pacific Medical Journal - 2018. - № 4 (74). - Pp. 45-48. https://www.elibrary.ru/item.asp?id=36403069
  2. Копычева И.И. Причины старения организма // Наука. – 2020. – №2 (18). – С. 21–25. Kopycheva I.I. Causes of aging of the body // The science. – 2020. – Vol. 2 (18). – Pp. 21–25. https://cyberleninka.ru/article/n/prichiny-stareniya-organizma
  3. Михалева И.А., Ноздрачева Е.В. Влияние биохимических показателей липидного обмена на функциональное состояние сердечно-сосудистой системы человека // Ученые записки Брянского государственного университета. – 2020. – №4 (20). – С. 74–78. Mihaleva I.A., Nozdracheva E.V. The influence of biochemical indicators of lipid metabolism on the functional state of the human cardiovascular system // Scientific notes of Bryansk State University. - 2020. - Vol.4(20). - Pp 74-78 https://cyberleninka.ru/article/n/vliyanie-biohimicheskih-pokazateley-lipidnogo-obmena-na-funktsionalnoe-sostoyanie-serdechno-sosudistoy-sistemy-cheloveka
  4. Chung K.W., Lee E.K., Lee M.K. [et al.] Impairment of PPARalpha and the fatty acid oxidation pathway aggravates renal fibrosis during aging. Journal of the Amarican Society of Nephrology. 2018;29:1223–1237. https://pubmed.ncbi.nlm.nih.gov/29440279/
  5. Garvin P., Nilsson L., Carstensen J., Jonasson L. [et al.] Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS One. 2008;3(3):e1774. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258002/
  6. Mancuso P., Bouchard B. The impact of aging on adipose function and adipokine synthesis. Frontiers of Endocrinology. 2019;10:137. https://pubmed.ncbi.nlm.nih.gov/30915034/
  7. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circulation Research. 2003;92 (11):1254–1261. https://pubmed.ncbi.nlm.nih.gov/12750310/
  8. Pietrzak J., Mirowski M., Jeleń A. et al. Decreased MMP1 gene expression in acute myeloid leukaemia. Mol Biol Rep 46, 2293–2298 (2019). https://doi.org/10.1007/s11033-019-04685-y
  9. https://link.springer.com/article/10.1007/s11033-019-04685-y
  10. Simões G., Pereira T., Caseiro A. Matrix metaloproteinases in vascular pathology. Microvascular Research. 2022;143:104398. https://pubmed.ncbi.nlm.nih.gov/35671836/
  11. Wang X. Khalil R.A. Matrix metalloproteinases, vascular remodeling, and vascular disease. Advances in Pharmacology. 2018; 81: 241–330. https://pubmed.ncbi.nlm.nih.gov/29310800/

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Chepurnova S., Jushhuk V.N., Markelova E.V., Visjagina M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies